[Health economic evaluation of recommended drug treatment].
Institutet för hälso- och sjukvårdsekonomi, Lund. sj@ihe.se
Stefan
S
Jendteg
Ulf
U
Persson
Anders
A
Anell
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004358:Drug Therapy / Q000191:economics*; D019317:Evidence-Based Medicine; D006292:Health Priorities; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D017410:Practice Guidelines as Topic; D013548:Sweden